Results 21 to 30 of about 4,650 (177)

Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2).

open access: yesPLoS ONE, 2021
SARS-CoV-2 variants are emerging with potential increased transmissibility highlighting the great unmet medical need for new therapies. Niclosamide is a potent anti-SARS-CoV-2 agent that has advanced in clinical development.
Anne Weiss   +7 more
doaj   +1 more source

Niclosamide for Covid-19: bridging the gap [PDF]

open access: yesMolecular Biology Reports, 2021
Niclosamide (NCL) is an anthelminthic drug, which is widely used to treat various diseases due to its pleiotropic anti-inflammatory and antiviral activities. NCL modulates of uncoupling oxidative phosphorylation and different signaling pathways in human biological processes.
Hayder M. Al-kuraishy   +4 more
openaire   +2 more sources

Involvement of Up-Regulation of DR5 Expression and Down-Regulation of c-FLIP in Niclosamide-Mediated TRAIL Sensitization in Human Renal Carcinoma Caki Cells

open access: yesMolecules, 2018
Niclosamide is used to treat intestinal parasite infections, as being an anthelmintic drug. Recently, several papers suggest the niclosamide inhibits multiple signaling pathways, which are highly activated and mutated in cancer.
Jeong Mi Yun   +5 more
doaj   +1 more source

Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer

open access: yesScientific Reports, 2021
Niclosamide has preclinical activity against a wide range of cancers. In prostate cancer, it inhibits androgen receptor variant 7 and synergizes with abiraterone. The approved niclosamide formulation has poor oral bioavailability.
Mamta Parikh   +9 more
doaj   +1 more source

Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition

open access: yesHeliyon, 2020
Niclosamide has been known to inhibit a number of pH-dependent viruses via the neutralization of endosomal acidic pH. It has also been shown to disrupt the mTORC1 signaling pathway. The replication of many viruses requires mTORC1 activation.
Nattamon Niyomdecha   +4 more
doaj   +1 more source

Disturbances to energy metabolism in juvenile lake sturgeon (Acipenser fulvescens) following exposure to niclosamide

open access: yesEcotoxicology and Environmental Safety, 2022
Since the 1960s, invasive sea lamprey (Petromyzon marinus) populations in the Laurentian Great Lakes have been controlled by applying two chemicals, 3-trifluoromethyl-4-nitrophenol (TFM) and 2’,5-dichloro-4’-nitrosalicylanilide (niclosamide, aka ...
R. Adrian Ionescu   +2 more
doaj   +1 more source

Long-term effect of niclosamide on inhibition of bacterial leaf blight in rice

open access: yesJournal of Plant Protection Research, 2016
Bacterial leaf blight is one of the major diseases in rice and affects yields. Thus, various methods have been applied to protect rice from this disease.
Kim Sung-Il   +3 more
doaj   +1 more source

Niclosamide as a Repurposing Drug against Corynebacterium striatum Multidrug-Resistant Infections

open access: yesAntibiotics, 2022
Corynebacterium striatum (C. striatum) is an emerging multidrug-resistant (MDR) pathogen associated with nosocomial infections. In this scenario, we screened the antimicrobial activity of the anthelmintic drugs doramectin, moxidectin, selamectin and ...
Veronica Folliero   +10 more
doaj   +1 more source

Presumed veterinary niclosamide-induced retinal toxicity in a human: a case report

open access: yesJournal of Medical Case Reports, 2023
Background To report the first case of bull’s eye maculopathy associated with veterinary niclosamide. Case presentation A 27-year-old Iranian female presented with a history of reduced vision and photopsia since 3 years, after accidental ingestion of ...
Fatemeh Bazvand   +2 more
doaj   +1 more source

Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis

open access: yesFrontiers in Pharmacology, 2019
Niclosamide is a traditional anti-tapeworm drug that exhibits potent anti-cancer activity. Our previous study showed that niclosamide induces cell cycle arrest in G1 phase. Nevertheless, the underlying mechanism remains unknown.
Zewen Han   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy